Related references
Note: Only part of the references are listed.Homoarginine and mortality in an older population: the Hoorn study
Stefan Pilz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
Symmetrical Dimethylarginine Predicts Mortality in the General Population Observations From the Dallas Heart Study
M. Odette Gore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
R Is for Arginine Metabolism of Arginine Takes off Again, in New Directions
Thomas Michel
CIRCULATION (2013)
Homoarginine Levels Are Regulated by L-Arginine: Glycine Amidinotransferase and Affect Stroke Outcome Results From Human and Murine Studies
Chi-un Choe et al.
CIRCULATION (2013)
Genome-Wide Association Study Identifies 3 Genomic Loci Significantly Associated With Serum Levels of Homoarginine The AtheroRemo Consortium
Marcus E. Kleber et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2013)
L-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome
Chi-un Choe et al.
HUMAN MOLECULAR GENETICS (2013)
Homoarginine - An independent marker of mortality in heart failure
Dorothee Atzler et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study
Leonard P. van der Zwan et al.
JOURNAL OF HYPERTENSION (2013)
Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients
S. Pilz et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study
Christiane Drechsler et al.
PLOS ONE (2013)
Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
Pietro Ravani et al.
PLOS ONE (2013)
Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine
Mariska Davids et al.
FEBS LETTERS (2012)
Homoarginine deficiency is associated with increased bone turnover
S. Pilz et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: The Dallas Heart Study
Lu Q. Chen et al.
ATHEROSCLEROSIS (2011)
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
Christiane Drechsler et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Low homoarginine concentration is a novel risk factor for heart disease
Stefan Pilz et al.
HEART (2011)
Low Serum Homoarginine Is a Novel Risk Factor for Fatal Strokes in Patients Undergoing Coronary Angiography
Stefan Pilz et al.
STROKE (2011)
Homoarginine, Cardiovascular Risk, and Mortality
Winfried Maerz et al.
CIRCULATION (2010)
Differential Associations Between Soluble Cellular Adhesion Molecules and Atherosclerosis in the Dallas Heart Study A Distinct Role for Soluble Endothelial Cell-Selective Adhesion Molecule
Anand Rohatgi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
Rainer H. Boeger et al.
CIRCULATION (2009)
Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond
RH Boger
ANNALS OF MEDICINE (2006)
Relation of coronary atherosclerosis determined by election beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study)
SM Abdullah et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
C Kragelund et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines
LE Bretscher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)